ZymoGenetics, Inc. Drug Gets Canadian Approval Published: Dec 16, 2009 ZymoGenetics, the Seattle-based biotech company, said today in a regulatory filing that its drug to control excess surgical bleeding has received approval from Canadian regulators. Related links Xconomy This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news